COMPREHENSIVE ASSESSMENT OF CLINICAL, LABORATORY, AND INSTRUMENTAL CHARACTERISTICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Authors

DOI:

https://doi.org/10.5281/zenodo.23643045

Keywords:

proinflammatory cytokines, oxidative stress, interleukin, coagulation

Abstract

Currently, considerable attention is being devoted to identifying the risk factors associated with the development of chronic obstructive pulmonary disease (COPD). Smoking is a major risk factor that contributes to the development of pathological processes in the lungs, including systemic inflammatory responses, oxidative stress, the production of inflammatory cytokines, increased procoagulant activity, enhanced oncogene expression, and other systemic effects. Proinflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) and interleukins (ILs), play an important role in disturbances of hemostasis in patients with chronic obstructive pulmonary disease (COPD). IL-6 is identified as a principal cytokine involved in activating coagulation processes, whereas TNF-α also affects coagulation, with IL-6 exerting an indirect influence. Furthermore, IL-8 contributes to the regulation of blood coagulation through its effects on the secretion of procoagulant and anticoagulant factors and plasminogen inhibitors.

References

1. Agustí, A., & Hogg, J. C. (2019). Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease. The New England Journal of Medicine, 381(13), 1248–1256. https://doi.org/10.1056/NEJMra1900475

2. Akhatova, V., et al. (2025). Stable Diffusion Model for Image Restoration to Enhance Low-Quality Satellite Images. 2025 3rd International Conference on Cyber Resilience (ICCR), 1–7.

3. Akhatova, V. P. 2025. ALTERNATIONS IN THE STRUCTURE OF THE BRONCHOPULMONARY AND CARDIOVASCULAR SYSTEMS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Журнал гуманитарных и естественных наук. 1, 21 [2] (May 2025), 17–21.

4. Barnes, Peter J. “Inflammatory mechanisms in patients with chronic obstructive pulmonary disease.” The Journal of Allergy and Clinical Immunology, vol. 138, no. 1 (2016): 16–27. DOI: 10.1016/j.jaci.2016.05.011а.

5. Caramori, G., Casolari, P., Barczyk, A. et al. COPD immunopathology. Seminars in Immunopathology, 38, 497–515 (2016). https://doi.org/10.1007/s00281-016-0561-5

6. Gilowska, I. (2014). CXCL8 (interleukina 8) — główny mediator stanu zapalnego w przewlekłej obturacyjnej chorobie płuc? [CXCL8 (interleukin 8) — the key inflammatory mediator in chronic obstructive pulmonary disease?]. Postępy Higieny i Medycyny Doświadczalnej (Online), 68, 842–850. https://doi. org/10.5604/17322693.1109219

7. Keer, R., Stirling, D., & Ludlam, C. A. (2001). Interleukin-6 and haemostasis. Br. J. Haematol, 115(1), 586–592.

8. Levi, M. (1999). Ten Cate H. Disseminated intravascular coagulation. N. Engl. J. Med, 341(8), 586–592.

9. Orlova EA, Kuzmichev BY, Orlov MA, Dorfman IP (2023). Yallig‘lanish biomarkerlari va surunkali obstruktiv o‘pka kasalligining muhim klinik fenotiplari o‘rtasidagi korrelyatsiya tahlili. Farmakologiyada tadqiqot natijalari, 9(1): 1–6. https://doi.org/10.18413/rrpharmacology.9.10004

10. Trushina, E. Yu. (2019). Surunkali obstruktiv o‘pka kasalligining immunopatogenezida IL-4, IL-6, IL-8, IL-10 sitokinlarining roli / E. Yu. Trushina, E. M. Kostina, B. A. Molotilov [va boshq.]. Tibbiy immunologiya, (1), 89–98.

11. Yao, X., Huang, J., Zhong, H., Shen, N., Faggioni, R., Fung, M., & Yao, Y. (2014). Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacology & Therapeutics, 141(2), 125–139. https:// doi.org/10.1016/j.pharmthera.2013.09.004

12. Ахатова, В. П., З. Ю. Сафарова, and С. Э. Чориев. “Изменение уровней матриксных металлопротеиназ в крови у больных с инфарктом миокарда.” Journal of Scientific Research, Modern Views and Innovations 1 (2024): 2.

13. Akhatova, V. P. (2025). — ALTERNATIONS IN THE STRUCTURE OF THE BRONCHOPULMONARY AND CARDIOVASCULAR SYSTEMS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE. New Day in Medicine 4(78).

14. Ахатова, В. П. “Проблемы в лечении сердечной недостаточности у пожилых пациентов.” American Journal of Modern World Sciences 1.6 (2024).

15. Axatova, V. P. (2025). SURUNKALI OBSTRUKTIV O‘PKA KASALLIGI BILAN OG‘RIGAN BEMORLARDA BRONX-O‘PKA TIZIMIDAGI O‘ZGARISHLARNING KLINIK XUSUSIYATLARI VA FUNKSIONAL KO‘RSATKICHLARI. Вестник Ассоциации Пульмонологов Центральной Азии, 8(3), 100–103.

16. Abduvokhidovna, I. Y., A. I. Rubenovna, and A. V. Pardakulovna. “Surunkali yurak yetishmovchiligi bilan og‘rigan bemorlarga ixtisoslashtirilgan tibbiy yordamni tashkil etish.” Journal of Biomedicine and Practice 7 (2022): 5.

17. Исмаилов Жамшид Абдураимович, Агабабян Ирина Рубеновна, Тураев Хикматилла Негматович, Ахатова Вазира Пардакуловна, Мирджалал Норчаев. ПОСЛЕДСТВИЯ ВОЗНИКНОВЕНИЯ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ В ДИАГНОСТИКЕ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ. (2022). JCRR, (4).

18. Axatova, V. P. (2025). O‘PKANING SURUNKALI OBSTRUKTIV KASALLIGI KLINIKASI VA IMMUNOLOGIK KO‘RSATKICHLARINING O‘ZARO BOG‘LIQLIGI. Вестник Ассоциации Пульмонологов Центральной Азии, 8(3), 81–85.

19. Ахатова, В. П., and Н. Ш. Рахмонова. Роль провоспалительных цитокинов при обострении хронической обструктивной болезни легких. Diss. БГМУ, 2022.

20. Исмаилов, Жамшид Абдураимович, and Ирина Рубеновна Агабабян. “Тураев Хикматилла Негматович, Ахатова Вазира Пардакуловна, Мирджалал Норчаев последствия возникновения хронической сердечной недостаточности в диагностике хронической обструктивной болезни легких.” (2022).

21. Закиряева, П. О., and В. П. Ахатова. “Благоприятное влияние снижения массы тела на дыхательную функцию у пациентов с интерстициальным заболеванием легких с ожирением.” Journal the Coryphaeus of Science 6.1 (2024).

22. Рахмонова, Н. Ш., and В. П. Ахатова. Зависимость значений индекса массы тела и уровня цистатина-С у больных на ранних стадиях инсулинорезистентности. Diss. БГМУ, 2022.

Downloads

Published

2026-10-20

How to Cite

1.
Vazira AP. COMPREHENSIVE ASSESSMENT OF CLINICAL, LABORATORY, AND INSTRUMENTAL CHARACTERISTICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. TTI [Internet]. 2026 Oct. 20 [cited 2026 Nov. 18];2(10):499-504. Available from: https://tibbiyot-talimi-va-innovatsiyalari.uz/index.php/TTI/article/view/196
Vol. 2 No. 10 (2026): Journal of "Medical Education and Innovations"